Principal Financial Group Inc Durect Corp Transaction History

Principal Financial Group Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.64 $15,736 - $26,503	-41,411 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.55 - $0.98 $1,554 - $2,770	2,827 Added 7.33%	41,411 $28,000
Q4 2021 Feb 09, 2022	SELL	$0.9 - $1.31 $9,609 - $13,986	-10,677 Reduced 21.67%	38,584 $38,000
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.61 $15,840 - $21,076	13,091 Added 36.19%	49,261 $63,000
Q2 2021 Aug 10, 2021	SELL	$1.6 - $2.02 $173,353 - $218,858	-108,346 Reduced 74.97%	36,170 $58,000
Q1 2021 May 10, 2021	BUY	$1.86 - $2.87 $282 - $436	152 Added 0.11%	144,516 $286,000
Q4 2020 Feb 08, 2021	BUY	$1.65 - $2.43 $30,696 - $45,207	18,604 Added 14.79%	144,364 $299,000
Q3 2020 Nov 06, 2020	BUY	$1.6 - $2.35 $68,884 - $101,174	43,053 Added 52.05%	125,760 $215,000
Q2 2020 Aug 05, 2020	BUY	$1.33 - $2.76 $110,000 - $228,271	82,707 New	82,707 $192,000
Q2 2019 Aug 12, 2019	SELL	$0.51 - $0.86 $15,151 - $25,549	-29,709 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$0.51 - $0.82 $678 - $1,090	-1,330 Reduced 4.28%	29,709 $19,000
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $10,875 - $24,922	-22,657 Reduced 42.19%	31,039 $15,000
Q3 2018 Nov 14, 2018	BUY	$1.06 - $1.69 $10,439 - $16,644	9,849 Added 22.46%	53,696 $59,000
Q2 2018 Aug 13, 2018	BUY	$1.56 - $2.51 $28,808 - $46,352	18,467 Added 72.76%	43,847 $0
Q1 2018 May 14, 2018	SELL	$0.91 - $2.24 $2,834 - $6,977	-3,115 Reduced 10.93%	25,380 $54,000
Q4 2017 Feb 13, 2018	BUY	$0.78 - $2.1 $2,509 - $6,755	3,217 Added 12.73%	28,495 $26,000
Q3 2017 Nov 02, 2017	BUY	$1.55 - $1.82 $39,180 - $46,005	25,278	25,278 $45,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.